ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,617Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 300

$398K Total Retail Price of All Prescriptions

Rank: 58 out of 300

136 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 136 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

29% of this provider’s 136 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 4,285 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $81 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
PRAVASTATIN SODIUM 202 137 1 15
LEVOTHYROXINE SODIUM 170 152 2 9
HYDROCODONE-ACETAMINOPHEN 156 122 S3 3 1
LISINOPRIL 154 87 4 4
METOPROLOL SUCCINATE 142 134 5 6
CLOPIDOGREL 142 98 5 18
FENOFIBRATE 124 94 7 98
FUROSEMIDE 124 116 7 3
CARVEDILOL 120 100 9 12
PLAVIX 100 79 10 24
ATORVASTATIN CALCIUM 98 77 11 14
CRESTOR 95 58 12 26
SIMVASTATIN 92 92 13 5
ZOLPIDEM TARTRATE 90 58 14 21
SPIRONOLACTONE 81 75 15 92
NEXIUM 80 54 16 17
ESCITALOPRAM OXALATE 79 70 17 78
NIASPAN 78 59 18 183
WARFARIN SODIUM 70 70 19 10
SERTRALINE HCL 68 56 20 41
AMLODIPINE BESYLATE-BENAZEPRIL 67 50 21 52
NIFEDIPINE ER 64 47 22 120
METFORMIN HCL 63 51 23 19
METOPROLOL TARTRATE 60 38 24 13
RAMIPRIL 58 56 25 63
DEXILANT 58 43 25 119
PRISTIQ ER 57 54 27 320
BENICAR 57 54 27 191
SYNTHROID 56 34 29 49
TAMSULOSIN HCL 55 50 30 8
GABAPENTIN 55 38 30 7
LOVAZA 54 41 32 129
AMLODIPINE BESYLATE 54 49 32 2
NAMENDA 54 54 32 48
ATENOLOL 52 40 35 31
PREDNISONE 51 48 36 33
FINASTERIDE 51 46 36 24
QUETIAPINE FUMARATE 50 32 38 79
POTASSIUM CHLORIDE 50 46 38 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.